Century Therapeutics, Inc. IPSC
1.20 USD -0.13 (-9.47%)
As ofNov 20, 2026, 2:33 PM EST
1.18 Day range 1.32
0.464 52-week range 3.04
- YTD
- +20.10%
- 1 year
- +143.38%
IPSC revenue history
Revenue is income from the company’s ordinary business activities.
109,164,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 109,164,000 | 102,575,000 | 1556.76% |
| FY 2024 | 2024-12-31 | 6,589,000 | 4,354,000 | 194.81% |
| FY 2023 | 2023-12-31 | 2,235,000 | -2,964,000 | -57.01% |
| FY 2022 | 2022-12-31 | 5,199,000 | 5,199,000 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:35.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
